Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ULTIMATE: Utilising Lifemap to Investigate Malignant Arrhythmia ThErapy

NCT02058771 is registered in ClinicalTrials.gov with University Hospitals, Leicester as lead sponsor.

NCT NCT02058771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ULTIMATE: Utilising Lifemap to Investigate Malignant Arrhythmia ThErapy
Lead sponsor
University Hospitals, Leicester
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
November 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, implantable defibrillator user, ischemic cardiomyopathy, myocardial infarction, sudden cardiac death